BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02551874-completion@plaintrial.com
DTSTAMP:20261027T011504Z
DTSTART;VALUE=DATE:20171110
SUMMARY:A 24-week Open-Label\, Phase 3b Trial With a 28-week Extension to E
 valuate the Efficacy and Safety of Saxagliptin Co-administered With Dapagl
 iflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who H
 ave Glycemic Control on Metformin — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02551874
URL:https://plaintrial.com/trial/NCT02551874
END:VEVENT
END:VCALENDAR